Awareness Of Use Of GLP-1 Agonists In The Treatment Of Diabetes Mellitus In Pakistan

J Pak Med Assoc. 2023 Aug;73(8):1769. doi: 10.47391/JPMA.8210.
No abstract available

MeSH terms

  • Diabetes Mellitus* / drug therapy
  • Glucagon-Like Peptide 1 / therapeutic use
  • Humans
  • Pakistan

Substances

  • Glucagon-Like Peptide 1